Anti-Obesity medications like Saxenda and Wegovy belong to a class of medications known as GLP-1 receptor agonists and have been gaining popularity as a weight-loss solution
El nuevo frmaco, que se administra en comprimidos, tiene un mecanismo de accin completamente diferente al de los conocidos frmacos basados en GLP-1, como Ozempic, que se administra mediante inyecciones
OASIS 1 met its primary endpoint of a statistically significant weight loss at week 68 in the oral semaglutide (50 mg) versus placebo group, whihch marks a milestone step toward the goal of an oral weight loss drug
Learn how this triple agonist affects fat loss, energy, and metabolic health beyond
These medicines work by mimicking a natural hormone that influences multiple metabolic processes, including blood sugar regulation, insulin secretion, and appetite control
These minor effects usually fade within a day or two